Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H21N2O3.Na |
Molecular Weight | 348.3714 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCCCC(C([O-])=O)C(=O)N(NC1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=JSKMFBFCHQMLJR-UHFFFAOYSA-M
InChI=1S/C19H22N2O3.Na/c1-2-3-14-17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15;/h4-13,17,20H,2-3,14H2,1H3,(H,23,24);/q;+1/p-1
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rosheta.com/en/2222/octomotol
110 mg twice daily
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID40932376
Created by
admin on Sat Dec 16 01:54:38 GMT 2023 , Edited by admin on Sat Dec 16 01:54:38 GMT 2023
|
PRIMARY | |||
|
14467-30-2
Created by
admin on Sat Dec 16 01:54:38 GMT 2023 , Edited by admin on Sat Dec 16 01:54:38 GMT 2023
|
PRIMARY | |||
|
PP47GRI92P
Created by
admin on Sat Dec 16 01:54:38 GMT 2023 , Edited by admin on Sat Dec 16 01:54:38 GMT 2023
|
PRIMARY | |||
|
23675792
Created by
admin on Sat Dec 16 01:54:38 GMT 2023 , Edited by admin on Sat Dec 16 01:54:38 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD